Biostar Pharmaceuticals, Inc.
No. 588 Shiji Xi Avenue
Xianyang City,
712046
China - Map
Phone: 86 29 3368 6638
Fax: 86 29 3368 5386
Website: http://www.biostarpharmaceuticals.com
| Index Membership: | N/A | | Sector: | Healthcare | | Industry: | Drug Manufacturers - Major | | Full Time Employees: | 439 |
|
Biostar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the Peoples Republic of China. Its principal product includes the Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for the treatment of chronic hepatitis B. The companys products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat pain, headache, and fever; and Tianqi Dysmenorrhea capsule, a traditional Chinese medicine used for the treatment of pain and other symptoms associated with menstruation. Its prescription pharmaceutical products include Danshen granule for the treatment of coronary heart disease, myocarditis, and angina pectoris; and Taohuasan pediatric medicine for the treatment of bronchial congestion and coughs in children. In addition, the company manufactures hernia belt, a medical device used for the relief of hernia. Further, it provides nutrient and OTC products, which comprise Tangning capsule for the treatment of diabetes; Yizi capsule for fertility; Shengjing capsule for kidney; and Aoxing ointment to treat psoriasis, vitiligo, and various dermatitis. Biostar Pharmaceuticals, Inc. sells its products through distributors and a network of dedicated sales people in approximately 25 provinces. The company was founded in 1995 and is headquartered in Xianyang City, the Peoples Republic of China. Key Statistics
| |
| | Pay | Exercised | Mr. Ronghua Wang Ph.D.,
58
Chairman, Chief Exec. Officer, Pres, Chairman of Aoxing Pharmaceutical Inc, Chief Exec. Officer of Aoxing Pharmaceutical Inc and Pres of Aoxing Pharmaceutical Inc | 17.00k | 0.00 | Ms. Qinghua Liu ,
46
Interim Chief Financial Officer, Principal Accounting Officer and Director | 10.00k | 0.00 | Mr. Zhenghong Wang ,
33
Chief Operating Officer | 4.00k | 0.00 | Mr. Haipeng Wu ,
56
Independent Director, Chairman of Nominating & Governance Committee, Member of Audit Committee and Member of Compensation Committee | 4.00k | N/A | Mr. Zhongyang Shang ,
62
Independent Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee | 3.00k | N/A |
|
| | Amounts are as of 31-Dec-2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.02(2.60%) 1:29AM